Narcolepsy drugs Market Overview:
Narcolepsy is a chronic neurological disorder that is characterized by brain’s inability to control the sleep-wake cycle of an individual. This disorder is not caused because of any mental illness, but is mainly caused due to genetic abnormalities occurring from environmental factors or biologic factors. Narcoleptic individuals exhibit a typical characteristic symptom, i.e. excessive daytime sleepiness (EDS), where people experience disturbed night sleep and abnormal daytime sleep pattern. Narcolepsy disorder is often confused with insomnia. Other key symptoms of this disorder include, cataplexy, sleep paralysis, hypnagogic hallucinations, automatic behavior and night weakness.
Narcolepsy drugs Market drivers and restraints:
Some of the key factors driving the growth of this market include rising prevalence of several sleep disorders including narcolepsy, increasing awareness about the disorder and increasing demand for advanced therapeutics and diagnostics. Narcoleptic disorder is equally prevalent to Parkinson’s disease or multiple sclerosis and is more prevalent than cystic fibrosis. There are more than 3 million people suffering from this disorder globally. Increasing awareness about the disorder, and the resultant rise in demand for new and innovative drugs and other treatment options will result in the growth of this market in future.
To know more, click on the link below:
https://www.marketdataforecast.com/market-reports/north-america-narcolepsy-drugs-Market
Report segmented as:
By disease type:
• daytime extreme sleepiness
• cataplexia
• others
By therapeutic type:
• central nervous system stimulants
• tricyclic antidepressants
• sodium oxybate
• selective serotonin reuptake inhibitor
• others


View a sample and decide:
https://www.marketdataforecast.com/market-reports/north-america-narcolepsy-drugs-Market/request-sample
Geographical analysis:
Geographically, North America leads the world narcolepsy drug market followed by Europe. Major factors responsible for their dominance are high prevalence rate of narcolepsy in these regions. U.S. alone accounts for more than 200,000 narcoleptic individuals and is also characterized by high awareness levels among the general population. Asia-Pacific region exhibited fastest growth in this market due to rising awareness levels about the disease and its treatment options and elevating spending power of the population.
Important market players:
Some of the major players operating in this market are Addrenex Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., BIOPROJET, Cephalon, Inc., Evotec AG, Graymark Healthcare, Inc., Hypnion, Inc., Jazz Pharmaceuticals, Inc., Ligand Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd.
The Scope of the report:
This report offers the current product and services market evaluation and the future estimation of the market. It helps us understand the market better through size anticipation and CAGR calculation to estimate the next market. It has a broader segmentation for better understanding of the enterprising of the market at a low level by segregating the market into smaller sectors.
Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
Check for discount: https://www.marketdataforecast.com/market-reports/north-america-narcolepsy-drugs-Market/discount
About Us:
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
For more information:
Abhishek Shukla
Sales Manager at Market Data Forecast
Email: [email protected]
Tel: +1-888-702-9626
Website: https://www.marketdataforecast.com/